Sign Up to like & get
recommendations!
0
Published in 2025 at "Endocrine"
DOI: 10.1007/s12020-025-04293-w
Abstract: “Ozempic face” and facial aging have been observed as side effects in many patients after glucagon like peptide 1 receptor agonists (GLP-1RA) therapy for type 2 diabetes mellitus (T2DM) and obesity. However, those medications can…
read more here.
Keywords:
possible skin;
glp 1ra;
skin aging;
1ra possible ... See more keywords